Product description

Temozolomide is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.

Temozolomide API has got Chinese local GMP certificate.
Read more

Specifications

Categories APIs
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from China

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers